Pages that link to "Q36238013"
Jump to navigation
Jump to search
The following pages link to The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease. (Q36238013):
Displaying 24 items.
- Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases (Q24670337) (← links)
- The role of physical exercise in inflammatory bowel disease (Q26865777) (← links)
- Adipokines and the role of visceral adipose tissue in inflammatory bowel disease (Q28070229) (← links)
- Defective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patients (Q33699974) (← links)
- The Impact of Obesity on the Clinical Course of Inflammatory Bowel Disease: A Meta-Analysis. (Q33772167) (← links)
- The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course (Q34526079) (← links)
- Gingival crevicular fluid and serum levels of resistin in obese and non-obese subjects with and without periodontitis and association with single nucleotide polymorphism at -420 (Q34553317) (← links)
- Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction level (Q34947204) (← links)
- Metabolic syndrome frequency in inflammatory bowel diseases (Q35564312) (← links)
- Differential effects of energy balance on experimentally-induced colitis. (Q35761692) (← links)
- Melanin-concentrating hormone as a mediator of intestinal inflammation. (Q36802510) (← links)
- Retinol Binding Protein 4 in children with Inflammatory Bowel Disease: a negative correlation with the disease activity (Q37083027) (← links)
- Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective (Q37625213) (← links)
- Leptin-activity blockers: development and potential use in experimental biology and medicine (Q38151768) (← links)
- The bone and fat connection in inflammatory bowel diseases. (Q38225220) (← links)
- Mesenteric panniculitis: an update (Q38249074) (← links)
- Novel multiplex method to assess insulin, leptin and adiponectin regulation of inflammatory cytokines associated with colon cancer (Q39423635) (← links)
- Plasma ghrelin and leptin in patients with inflammatory bowel disease and its association with nutritional status (Q42203617) (← links)
- Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population (Q43087820) (← links)
- Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease. (Q44209841) (← links)
- Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather than hyperinsulinemia. (Q46595134) (← links)
- The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm. (Q48021336) (← links)
- Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease. (Q50899263) (← links)
- Is obesity a risk factor for Crohn's disease? (Q83164329) (← links)